Drug-Induced Scleroderma and Sclerodermiform Conditions
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 16 (3) , 353-366
- https://doi.org/10.1016/s0738-081x(98)00006-6
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Severe fibrosis in a patient with scleroderma and previous radiotherapy—a case report and literature reviewThe British Journal of Radiology, 1996
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- L-Tryptophan and the Eosinophilia-Myalgia Syndrome: Current Understanding of the Etiology and PathogenesisJournal of Investigative Dermatology, 1993
- Silica-induced sclerodermaJournal of the American Academy of Dermatology, 1990
- Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: A spectrum of sclerodermatous skin diseaseJournal of the American Academy of Dermatology, 1990
- Parenteral pentazocine: Cutaneous complications revisitedJournal of the American Academy of Dermatology, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Cutaneous reactions to vitamin KJournal of the American Academy of Dermatology, 1988
- Development of a Scleroderma-like Illness during Therapy with L-5-Hydroxytryptophan and CarbidopaNew England Journal of Medicine, 1980
- Skin manifestations of pentazocine abusePublished by Elsevier ,1980